Gene Therapy, RNA and Pens at European Hemophilia Congress in ParisLabiotech.eu (blog)Among the most interesting presented at the congress are new results on gene therapy and RNAi, a pen to treat hemophilia and many companies fighting to reduce the dos… Continue reading
|
Regrowing heart muscles without cancer risk, using synthetic stem cells
Genetic Literacy Project A new revolutionary stem cell technique is being used to treat those suffering from damaged muscles without the cancer risk that was previously present. This was the first time that researchers had successfully implanted synthetic stem cardiac cells … Stem Cells – Types, Technologies and Therapeutics Market Research Report 2022EIN News (press release) Future of Global Stem Cell Assay Market: 2016 – 2024Satellite PR News (press release) Researchers engineer new thyroid cellsPhys.Org |
Genetic Literacy Project |
Will consumers accept non-browning mushroom developed through CRISPR gene editing?
Genetic Literacy Project “This mushroom will be looked on by consumers as a GMO item even though the CRISPR technology does not introduce genetic material taken from a different organism as does the traditional method of gene splicing/replacement,” said [Vince Versagli, sales … |
Futurism |
A Real Life “Hibernation Chamber” is Being Made Deep Space Travel
Futurism Science fiction conveniently sidesteps this challenge by putting the space explorers into deep sleep–a state of suspended animation. But slowing the human metabolism down while ensuring that a person will stay alive for extended periods is a lot easier … |
|
Doudna and Charpentier Receive 2017 Japan Prize for CRISPR Contribution
Genetic Engineering & Biotechnology News The impact that the genome editing tool CRISPR-Cas9 has had on life science research is almost immeasurable, as the number of research projects utilizing the cutting edge molecular technique has exploded since its initial description as a molecular … 2017 Japan Prize Honors Trailblazers in Life Science and CryptographyYahoo Finance |
Curetoday.com |
Immunotherapy 2.0 is ASCO’s Cancer Advance of the Year
Curetoday.com With five agents approved in 2016 alone, immunotherapy continues to revolutionize the treatment paradigms for a number of different cancers. Recognizing the impact that these agents have had over the past year, the American Society of Clinical Oncology … Report: Trump Administration Should Continue Funding Cancer ResearchPublic News Service |
|
First-of-its-kind Study Explores Stem Cells as Treatment for CF Patients
Cystic Fibrosis News Today An Ohio cystic fibrosis (CF) patient was given an infusion of adult stem cells in a pioneering study that researchers hope will lead to therapies that reduce inflammation and infections linked to the disease. “I am hoping the future generations of CF … |